03. September 2026
14:00 - 19:00 Uhr
Keynote speeches, short presentations and panel discussions in which trends and innovation across various sectors are discussed.
For anyone who wants to break down silos and help shape the future of Switzerland’s life sciences sector through genuine cross-sector innovation.
Switzerland offers key conditions for innovative ideas and solutions, yet growth and value creation are increasingly taking place abroad. The event will discuss how the country can maintain its excellence and avoid a shift to more attractive locations. tfz Innovation Inside Pharma is the innovation hub for a cross-sector networked pharmaceutical hub in Switzerland. We bring together over 100 top decision-makers from industry, cutting-edge research and public authorities to highlight technological trends and jointly shape the healthcare of tomorrow – in a practical, networked and solution-oriented way.
| 14:00 Uhr | Meet & Greet, Coffee |
| 14:30 Uhr | Start Programme featuring exciting keynote speeches and power slots |
| 15:45 Uhr | Networking |
| 16:00 Uhr | Programme continues with power slots and interactive panel discussion |
| 17:15 Uhr | Networking & Aperitif |
Geopolitical shifts, regulatory pressure and the global race for innovation: in his opening keynote address, Interpharma CEO René Buholzer addresses the most pressing issues concerning the future of patient care in Switzerland and outlines how Switzerland can maintain its leading position in a volatile world.
From a Basel-based laboratory to a billion-dollar exit: in his keynote speech, Dr Simon Ittig (T3 Pharmaceuticals) explains how radical approaches such as bacterial cancer therapy are being successfully integrated into the pipelines of big pharma, and what framework conditions Switzerland now needs to retain cutting-edge research within the country.
From US pioneer to Zug-based innovation leader: why has a global market leader in AI-driven antibody development chosen Switzerland as the location for its expansion? Hear directly from Absci what, in their view, makes Switzerland such a special location in the global marketplace.
The bridge between laboratory diagnostics and clinical safety: TransHeps demonstrates how data-driven early detection of drug toxicity prevents billions in losses during drug development and will be expanded to other organs as a future platform.
CEO & Delegate of the Board, Interpharma
Member of the National Council, member of the Committee on Social Security and Health and the Committee on Economic Affairs and Taxation
Head of Translational Research, Absci
The Zug Technology Forum would like to extend its sincere thanks to the ‘tfz Enabler’, Zuger Kantonalbank, and the other sponsors of tfz Innovation Inside Pharma 2026.